Home › Calculator › SHPMY Dividend Calculator 2026
SHPMY DRIP Calculator & Dividend Yield 2026
4.96% YieldHealthcareShanghai Pharmaceuticals Holding Co., Ltd · OTC
Price: $6.90 · Annual div: $0.3421/share · Frequency: annual · Payout ratio: 4% · Ex-div: 2026-09-17
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SHPMY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
SHPMY Dividend History — Last 16 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-17Latest | 2026-11-12 | $0.0744 | 5.75% | $7.24 |
| 2026-07-16 | 2026-09-14 | $0.2577 | 7.42% | $7.34 |
| 2025-12-31 | 2026-02-23 | $0.0844 | 3.49% | $8.23 |
| 2025-07-17 | 2025-09-09 | $0.2025 | 7.91% | $6.83 |
| 2024-09-19 | 2024-11-12 | $0.0561 | 5.10% | $6.63 |
| 2024-07-19 | 2024-09-11 | $0.2819 | 3.80% | $7.41 |
| 2023-07-17 | 2023-09-12 | $0.4210 | 7.53% | $9.74 |
| 2022-07-21 | 2022-09-13 | $0.3120 | 3.65% | $8.55 |
| 2021-07-14 | 2021-09-13 | $0.3700 | 6.06% | $11.22 |
| 2020-07-15 | 2020-09-08 | $0.3104 | — | — |
| 2019-07-11 | 2019-09-09 | $0.2995 | — | — |
| 2018-07-11 | 2018-09-10 | $0.2938 | — | — |
| 2017-07-10 | 2017-09-05 | $0.2642 | — | — |
| 2016-07-13 | — | $0.2505 | — | — |
| 2015-06-15 | — | $0.2371 | — | — |
| 2014-05-22 | — | $0.2112 | — | — |
About Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) — Dividend Analysis 2026
Shanghai Pharmaceuticals Holding Co., Ltd. operates as an investment holding enterprise deeply embedded in China's pharmaceutical and healthcare industries. The company oversees a full range of activities, from the research and development of new drugs to their manufacturing, nationwide distribution, and retail sales of a diverse array of pharmaceutical and health-related products. Its operations are strategically managed across four primary divisions: Production, Distribution, Retail, and Other services. The company's extensive product catalog includes chemical compounds, biochemicals, traditional Chinese remedies, general healthcare items, and medical devices. These offerings are designed to address a broad spectrum of medical conditions, encompassing oncology, cardiovascular and cerebrovascular issues, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory conditions. Notably, their portfolio boasts over 700 distinct pharmaceutical formulations. Beyond product development and manufacturing, Shanghai Pharmaceuticals is a significant player in comprehensive pharmaceutical supply chain management. This involves sophisticated distribution, warehousing, logistics, and various value-added services, all provided to a wide range of clients including drug manufacturers and healthcare providers such as hospitals, other wholesalers, and individual retail pharmacies. Moreover, the company maintains a substantial retail footprint, managing an extensive network of roughly 2,000 chain pharmacies spread across 24 provinces, alongside a thriving online drug commerce platform. Its diverse service offerings further extend to consulting, asset management, facilitating clinical trials, offering medical assistance, educating both medical professionals and patients, handling electronic prescriptions, and pioneering remote and cloud-based hospital solutions. Established in Shanghai in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. functions as a subsidiary under Shanghai Pharmaceutical (Group) Co., Ltd.
Similar dividend stocks to SHPMY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SHPMY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SHPMY position with:
🌍 SHPMY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SHPMY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.96% | 2.16% | $496 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.22% | 1.42% | $422 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.97% | 1.17% | $397 / yr |
| 🇬🇧 UK ISA | 0% | 4.96% | 2.16% | $496 / yr |
| 🇬🇧 UK Taxable | 8.75% | 4.53% | 1.73% | $453 / yr |
| 🇨🇦 TFSA | 0% | 4.96% | 2.16% | $496 / yr |
| 🇨🇦 CA Taxable | 25% | 3.72% | 0.92% | $372 / yr |
| 🇦🇺 Super (pension) | 15% | 4.22% | 1.42% | $422 / yr |
| 🇦🇺 AU Taxable | 30% | 3.47% | 0.67% | $347 / yr |
| 🇩🇪 DE Taxable | 26.375% | 3.65% | 0.85% | $365 / yr |
| 🇫🇷 FR Taxable | 30% | 3.47% | 0.67% | $347 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SHPMY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.34/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SHPMY Dividend Payment Schedule
SHPMY pays quarterly — 4 times per year. Ex-div: 2026-09-17.
📊 SHPMY vs Healthcare Benchmarks
How SHPMY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SHPMY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SHPMY Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare SHPMY with peers: SHPMY vs BIMI · SHPMY vs CHME · SHPMY vs CSWYY
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SHPMY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) is currently trading at $6.90, 16% below its 52-week high. The current dividend yield is 4.96% based on an annual payout of $0.3421 per share.
SHPMY (Shanghai Pharmaceuticals Holding Co., Ltd) — 4.96% Dividend Yield Analysis
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) is a healthcare stock currently trading at $6.89 with a dividend yield of 4.96%. It pays an annual dividend of $0.3421 per share. The payout ratio of 4% suggests the dividend is well-covered by earnings. Over the past 5 years, SHPMY has grown its dividend at a compound annual rate of 11.4%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SHPMY News
LiveHow investors use the SHPMY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.